August 5, 2016
Rohto CEO Kunio Yamada (second right) Rohto Pharmaceutical and Osaka University Graduate School of Medicine announced on August 2 the establishment of a joint research course to accelerate the commercialization of regenerative medicine products using mesenchymal stem cells. Through the...read more